StockNews.com assumed coverage on shares of Oragenics (NYSEAMERICAN:OGEN – Free Report) in a research note released on Saturday. The firm issued a sell rating on the biotechnology company’s stock. Oragenics Price Performance Shares of NYSEAMERICAN OGEN opened at $3.65 on Friday. Oragenics has a fifty-two week low of $2.60 and a fifty-two week high of […]